Utilization of the common functional groups in bioactive molecules: Exploring dual inhibitory potential and computational analysis of keto esters against α-glucosidase and carbonic anhydrase-II enzymes
作者:Imtiaz Khan、Ajmal Khan、Sobia Ahsan Halim、Majid Khan、Sumera Zaib、Balqees Essa Mohammad Al-Yahyaei、Ahmed Al-Harrasi、Aliya Ibrar
DOI:10.1016/j.ijbiomac.2020.11.170
日期:2021.1
community to design and develop new and potent inhibitors of α-glucosidase with better pharmacokinetic properties. In this perspective, we demonstrate the successful integration of common functional groups (ketone & ester) in one combined pharmacophore which is favorable for the formation of hydrogen bonds and other weaker interactions with the target proteins. These keto ester derivatives were screened
糖尿病是一种进行性慢性疾病,以碳水化合物的代谢异常为特征,伴有严重的健康并发症,包括长期功能障碍或某些器官衰竭,心血管疾病和微血管病(神经病,肾病,视网膜病)。尽管存在各种不同的化学结构库-α-葡萄糖苷酶抑制剂,但由于与这些抑制剂相关的不良副作用(如腹胀,肠胃气胀,腹泻和肝损害),糖尿病治疗受到限制,这鼓励医学研究界设计和开发新的和有效的α抑制剂-葡糖苷酶具有更好的药代动力学特性。从这个角度出发,我们证明了在一个组合药效团中常见功能基团(酮和酯)的成功整合,这有利于氢键的形成以及与目标蛋白的其他较弱的相互作用。对这些酮酯衍生物的α-葡萄糖苷酶抑制潜力进行了筛选,体外结果表明,化合物3c是一种高活性抑制剂,与阿卡波糖相比,IC 50值为12.4±0.16μM(IC 50 = 942±0.74μM)。这种抑制能力比阿卡波糖高约76倍。其他有效化合物为3f(IC 50 = 28.0±0.28μM),3h(IC